TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›GYRO
GYRO logo

GYRO

Gyrodyne, LLC

Next earnings Aug 6, 2026

Hold
$6.13
▲ 0.00%
$6.13▼ -28.80%
over 1Y
L $6.00H $10.74
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W+0.1%
1M-7.7%
3M-23.3%
YTD-33.7%
1Y-28.8%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
F
Valuation
Fair value
Filings
Clean
Hold
Conviction
Horizon
Long (>12mo)

Sub-scale real-estate liquidation play trading ~half of book, but the value catalyst is stuck in Article 78 litigation and the data is thin.

Market cap $13.5M · 2026-07-04

Gyrodyne isn't a going-concern operator to be valued on earnings — the 10-K states plainly it is executing a "strategic plan of positioning our remaining properties for sale at enhanced values and making distributions to our shareholders." So the only question that matters is NAV versus price. On the provided FY2025 balance sheet, total assets are $58.7M against total liabilities of $32.8M, implying roughly $25.9M of net book equity; against a $13.5M market cap (2.20M shares × $6.13) the stock trades near half of depreciated book. For a liquidation vehicle whose entire thesis is realizing property value at or above carrying cost, that discount is the source of any upside — and it's a real margin of safety, which is why this is a hold and not an outright avoid.

But the catalyst is jammed. The value-enhancement rests on entitlements: the Town of Smithtown Planning Board granted preliminary approval to subdivide Flowerfield into eight lots in March 2022, and the Village of Head of the Harbor immediately filed an Article 78 proceeding to annul it — litigation that the MD&A still lists as a live risk in the FY2025 filing, i.e. roughly four years unresolved. Management concedes it "cannot assure you that we will realize growth in the value of our Flowerfield and Cortlandt Manor properties that exceeds our land entitlement costs or any at all." Meanwhile the clock and the balance sheet work against holders: cash fell 23.2% to $4.53M, total liabilities rose 26.0% to $32.8M in a single year, and the operating footprint is tiny — two developed properties, 161,430 sq ft, 82% leased to 31 tenants. Leases representing 52.18% of gross annual rent expire in 2026, adding near-term income risk on top of the entitlement overhang.

Is GYRO a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~90d expiry
  • Long 100 shares @ ~6.13
  • Short call 6.5 @ ~0.22 est
debit $591max +$59max −$590BE 5.91

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY14
Revenue$2.80M
Gross profit—
Operating income—
Net income-$3.11M
Diluted EPS-$2.09
Net margin-111.0%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-23.1%
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt$10.9M
Net cash-$6.34M

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. 10-Q Quarterly report2026-05-13

    Q1'26: liquidation ongoing, portfolio 82% leased, cash burn continues

  2. 10-K Annual report2026-03-27

    FY25: liabilities +26%, cash -23%; Article 78 suit still stalls Flowerfield sale

  3. 8-K Material agreement2026-01-12

    Entered new material definitive agreement (item 1.01) — advances property monetization

  4. 10-Q Quarterly report2025-11-10

    Q3'25: liquidation continues, portfolio steady at ~82% leased

  5. 8-K Shareholder vote2025-11-07

    Annual meeting voting results reported (item 5.07); routine governance

  6. 8-K Reg FD disclosure2025-11-05

    Reg FD investor update/press release (item 7.01); no financial commitment

  7. 8-K Material agreement2025-10-17

    Annual meeting proxy; board election/governance items up for shareholder vote

  8. DEF 14A Proxy statement2025-10-17

    Annual meeting proxy; board election/governance items up for shareholder vote

  9. 10-Q Quarterly report2025-08-08

    Q2'25: steady leasing, awaiting entitlement and sale progress

Recent filings

all on EDGAR ↗
10-QPeriod ending 2026-03-312026-05-13open ↗10-KPeriod ending 2025-12-312026-03-27open ↗8-KPeriod ending 2026-01-062026-01-12open ↗10-QPeriod ending 2025-09-302025-11-10open ↗8-KPeriod ending 2025-11-052025-11-07open ↗8-KPeriod ending 2025-11-052025-11-05open ↗SCHEDULE 13D/AFiling2025-10-20open ↗DEF 14APeriod ending 2025-11-052025-10-17open ↗8-KPeriod ending 2025-10-162025-10-17open ↗4Period ending 2025-09-082025-09-08open ↗PREC14AFiling2025-09-08open ↗PRE 14APeriod ending 2025-09-052025-09-05open ↗

Quality score

F
ValueGrowthProfitHealthMom.
ValueC
Growth—
ProfitabilityF
Financial healthC
MomentumF
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
6.0052-week10.74
Revenue
$2.80M
Net margin
-111.0%
ROE
-7.1%
P/E
—

SEC fundamentals · FY 2025

Revenue$2.80M
Net income-$3.11M
Diluted EPS-$2.09
Cash & equivalents$4.53M-23.2%
Total assets$58.7M+3.6%
Total liabilities$32.8M+26.0%
Stockholders' equity$43.9M+87.2%
L/E: 0.75x

Frequently asked

Is Gyrodyne, LLC (GYRO) a buy?
GYRO currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Sub-scale real-estate liquidation play trading ~half of book, but the value catalyst is stuck in Article 78 litigation and the data is thin.
What is Gyrodyne, LLC's quality score?
GYRO scores 38.32871835443038/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001589061, latest 10-Q filed 2026-05-13) · EODHD · Proprietary analysis · as of 7/4/2026, 5:23:17 AM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 1:23 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2025-09-08
TOWERVIEW LLC
10% owner
Sell1.97K @ $12.55$24.8K
2025-08-04
TOWERVIEW LLC
10% owner
Sell1.22K @ $12.10$14.7K
2024-10-21
TOWERVIEW LLC
10% owner
Sell350.00 @ $10.55$3.69K
2024-10-18
TOWERVIEW LLC
10% owner
Sell3.27K @ $11.75$38.4K
2024-10-18
TOWERVIEW LLC
10% owner
Sell3.38K @ $11.10$37.6K
2024-08-09
TOWERVIEW LLC
10% owner
Buy1.00K @ $7.77$7.77K
2024-05-02
TOWERVIEW LLC
10% owner
Buy1.85K @ $7.80$14.4K
2024-05-01
TOWERVIEW LLC
10% owner
Buy424.00 @ $7.83$3.32K
2024-04-16
TOWERVIEW LLC
10% owner
Buy2.43K @ $7.84$19.1K
2024-04-01
LAMB PAUL L
Director
Sell4.37K @ $7.99$34.9K
2024-03-12
LOEB JAN H
Director
Acquired (J)3.63K @ $8.00$29.1K

Dividends

Irregular
Yield (TTM)
—
Annual / share
—
Last ex-date
2017-06-23
Last amount
$1.00
ex 2017-06-23paid 2017-07-07$1.00
ex 2016-09-07paid 2016-09-15$1.50
ex 2016-06-16paid 2016-06-15$9.25
ex 2014-09-24paid 2014-12-31$4.60
ex 2013-12-31$458.12
ex 2012-12-17$382.60

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Recent news

market news →
Gyrodyne Announces Agreement with Star Equity FundBullish
globenewswire.com· 2025-10-17
Towerview LLC sells Gyrodyne (GYRO) shares worth $14,713Bullish
investing.com· 2025-08-05
GYRODYNE, LLC ANNOUNCES AGREEMENT TO SELL 49-ACRE PARCEL IN SMITHTOWN, NEW YORK AS PART OF STRATEGIC LIQUIDATION PLANBullish
globenewswire.com· 2025-08-04
Star Equity Fund Responds to Gyrodyne Board’s Entrenchment TacticsBullish
globenewswire.com· 2023-06-21
Gyrodyne Confirms Receipt of Star Equity’s Notice of Intent to Nominate Two Director Candidates at the 2023 Annual MeetingBullish
globenewswire.com· 2023-04-28
Star Equity Fund Announces Nomination of Director Candidates at Gyrodyne, LLCBullish
globenewswire.com· 2023-04-28

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score38 vs 67
Revenue growth— vs 7.5%
Net margin-111.0% vs 10.0%
Return on equity-7.1% vs 12.0%
P/E— vs 26.2